FDA Approves Injectable Immunotherapy Drug

Cancer immunotherapies, anti-cancer treatments that target a patient’s own immune system, working to make it more effective, have revolutionized the field of oncology research over the past decade.  Immune checkpoint inhibitors (ICIs), one class of immunotherapies, work by “blocking” interactions between two proteins (a checkpoint and a ligand).  When a checkpoint protein binds its ligand, the body signals to the immune system, instructing a…